133 related articles for article (PubMed ID: 3958775)
1. Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma.
Vance RB; Kapp JP
J Neurooncol; 1986; 3(4):287-90. PubMed ID: 3958775
[TBL] [Abstract][Full Text] [Related]
2. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
Kapp JP; Vance RB
J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
[TBL] [Abstract][Full Text] [Related]
3. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
Kapp JP; Sanford RA
Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors.
Feun LG; Lee YY; Yung WK; Charnsangavej C; Savaraj N; Tang RA; Wallace S
Cancer Drug Deliv; 1986; 3(2):147-56. PubMed ID: 3708537
[TBL] [Abstract][Full Text] [Related]
6. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
[TBL] [Abstract][Full Text] [Related]
7. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view.
Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R
Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050
[TBL] [Abstract][Full Text] [Related]
8. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
Hochberg FH; Pruitt AA; Beck DO; DeBrun G; Davis K
J Neurosurg; 1985 Dec; 63(6):876-80. PubMed ID: 2997415
[TBL] [Abstract][Full Text] [Related]
9. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
Bobo H; Kapp JP; Vance R
J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
[TBL] [Abstract][Full Text] [Related]
10. Supraophthalmic carotid infusion for brain chemotherapy. Experience with a new single-lumen catheter and maneuverable tip.
Kapp JP; Parker JL; Tucker EM
J Neurosurg; 1985 Jun; 62(6):823-5. PubMed ID: 4039751
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
12. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
[TBL] [Abstract][Full Text] [Related]
13. Supraophthalmic intracarotid infusion of BCNU for malignant glioma.
Foo SH; Choi IS; Berenstein A; Wise A; Ransohoff J; Koslow M; George A; Lin J; Feigin I; Budzilovich G
Neurology; 1986 Nov; 36(11):1437-44. PubMed ID: 3762962
[TBL] [Abstract][Full Text] [Related]
14. Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.
Théron J; Villemure JG; Worthington C; Tyler JL
Neuroradiology; 1986; 28(2):118-25. PubMed ID: 3703233
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine].
Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM
Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067
[TBL] [Abstract][Full Text] [Related]
16. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
17. Supraophthalmic placement of microleak balloon catheters for intracranial chemotherapy infusion: complications and results of therapy.
Metes JJ; Lazo A; Wilner HI; Decker D; Barboza R
AJNR Am J Neuroradiol; 1985; 6(6):948-52. PubMed ID: 3934935
[No Abstract] [Full Text] [Related]
18. Visual system toxicity following intra-arterial chemotherapy.
Kupersmith MJ; Frohman LP; Choi IS; Foo SH; Hiesinger E; Berenstein A; Wise A; Carr RE; Ransohoff J
Neurology; 1988 Feb; 38(2):284-9. PubMed ID: 3340295
[TBL] [Abstract][Full Text] [Related]
19. Selective delivery of chemotherapeutic agents with a new catheter system.
Wolpert SM; Kwan ES; Heros D; Kasdon DL; Hedges TR
Radiology; 1988 Feb; 166(2):547-9. PubMed ID: 3336733
[TBL] [Abstract][Full Text] [Related]
20. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL
Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
